OBJECTIVE: To assess the clinical and hematological profile of PNH in children. METHODS: Clinical and laboratory features of children with PNH diagnosed in the past six years at our centre were reviewed. Various investigations done included a complete blood count and peripheral smear examination, plasma hemoglobin, urine hemosiderin, acid ham test, sucrose lysis test, immunophenotyping of erythrocytes by sephadex column gel card and of granulocytes by flow cytometry. There were 18 children with a marked male predominance (M 14: F 4). RESULTS: Pallor, jaundice, dark urine and bleeding manifestations were the major presenting complaints. One girl suffered an arterial stroke. All children had cytopenia in at least one cell line. Children were treated with danazol, stanazolol, prednisolone and cyclosporin A variously. Overall response rate was 61%. Children with classical PNH performed slightly better with response rates of 66% (6/9) as compared to aplastic anemia-PNH group which has a response rate of 55% (5/9). Amongst various variables only danazol correlated with better response (p=0.029). CONCLUSION: PNH is an uncommon disease in children and should be included in the differential diagnosis of children presenting with cytopenia.
OBJECTIVE: To assess the clinical and hematological profile of PNH in children. METHODS: Clinical and laboratory features of children with PNH diagnosed in the past six years at our centre were reviewed. Various investigations done included a complete blood count and peripheral smear examination, plasma hemoglobin, urine hemosiderin, acid ham test, sucrose lysis test, immunophenotyping of erythrocytes by sephadex column gel card and of granulocytes by flow cytometry. There were 18 children with a marked male predominance (M 14: F 4). RESULTS: Pallor, jaundice, dark urine and bleeding manifestations were the major presenting complaints. One girl suffered an arterial stroke. All children had cytopenia in at least one cell line. Children were treated with danazol, stanazolol, prednisolone and cyclosporin A variously. Overall response rate was 61%. Children with classical PNH performed slightly better with response rates of 66% (6/9) as compared to aplastic anemia-PNH group which has a response rate of 55% (5/9). Amongst various variables only danazol correlated with better response (p=0.029). CONCLUSION: PNH is an uncommon disease in children and should be included in the differential diagnosis of children presenting with cytopenia.
Authors: G Socié; J Y Mary; A de Gramont; B Rio; M Leporrier; C Rose; P Heudier; H Rochant; J Y Cahn; E Gluckman Journal: Lancet Date: 1996-08-31 Impact factor: 79.321
Authors: Linda Wainwright; Robert A Brodsky; Linda K Erasmus; Stelios Poyiadjis; Gita Naidu; Diane MacKinnon Journal: J Pediatr Hematol Oncol Date: 2003-02 Impact factor: 1.289
Authors: Christian Flotho; Brigitte Strahm; Udo Kontny; Ulrich Duffner; Anke M J Peters; Wolfgang Dupuis; Charlotte M Niemeyer Journal: Br J Haematol Date: 2002-07 Impact factor: 6.998
Authors: Álvaro Urbano-Ispizua; Petra Muus; Hubert Schrezenmeier; Antonio M Almeida; Amanda Wilson; Russell E Ware Journal: Haematologica Date: 2016-11-24 Impact factor: 9.941
Authors: Carmen P Escalante; Stephanie Chisolm; Juhee Song; Marsha Richardson; Ellen Salkeld; Etsuko Aoki; Guillermo Garcia-Manero Journal: Cancer Med Date: 2019-01-11 Impact factor: 4.452